Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors

被引:289
作者
Thomas, CE
Storm, TA
Huang, Z
Kay, MA
机构
[1] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA
关键词
D O I
10.1128/JVI.78.6.3110-3122.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Transduction of the liver with single-stranded adeno-associated virus serotype 2 (AAV2) vectors is inefficient; less than 10% of hepatocytes are permissive for stable transduction, and transgene expression is characterized by a lag phase of up to 6 weeks. AAV2-based vector genomes packaged inside AAV6 or AAV8 capsids can transduce the liver with higher efficiency, but the molecular mechanisms underlying this phenomenon have not been determined. We now show that the primary barrier to transduction of the liver with vectors based on AAV2 capsids is uncoating of vector genomes in the nucleus. The majority of AAV2 genomes persist as encapsidated single-stranded molecules within the nucleus for as long as 6 weeks after vector administration. Double-stranded vector genomes packaged inside AAV2 capsids are at least 50-fold more active than single-stranded counterparts, but these vectors also exhibit a lag phase before maximal gene expression. Vector genomes packaged inside AAV6 or AAV8 capsids do not persist as encapsidated molecules and are more biologically active than vector genomes packaged inside AAV2 capsids. Our data suggest that the rate of uncoating of vector genomes determines the ability of complementary plus and minus single-stranded genomes to anneal together and convert to stable, biologically active double-stranded molecular forms.
引用
收藏
页码:3110 / 3122
页数:13
相关论文
共 34 条
[1]   A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease [J].
Aitken, ML ;
Moss, RB ;
Waltz, DA ;
Dovey, ME ;
Tonelli, MR ;
McNamara, SC ;
Gibson, RL ;
Ramsey, BW ;
Carter, BJ ;
Reynolds, TC .
HUMAN GENE THERAPY, 2001, 12 (15) :1907-1916
[2]   Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males [J].
Arruda, VR ;
Fields, PA ;
Milner, R ;
Wainwright, L ;
De Miguel, MP ;
Donovan, PJ ;
Herzog, RW ;
Nichols, TC ;
Biegel, JA ;
Razavi, M ;
Dake, M ;
Huff, D ;
Flake, AW ;
Couto, L ;
Kay, MA ;
High, KA .
MOLECULAR THERAPY, 2001, 4 (06) :586-592
[3]   Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors [J].
Bartlett, JS ;
Wilcher, R ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2777-2785
[4]   Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein [J].
Burton, M ;
Nakai, H ;
Colosi, P ;
Cunningham, J ;
Mitchell, R ;
Couto, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12725-12730
[5]   Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors [J].
Chao, HJ ;
Liu, YB ;
Rabinowitz, J ;
Li, CW ;
Samulski, RJ ;
Walsh, CE .
MOLECULAR THERAPY, 2000, 2 (06) :619-623
[6]   Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia [J].
Ding, W ;
Yan, ZY ;
Zak, R ;
Saavedra, M ;
Rodman, DM ;
Engelhardt, JF .
JOURNAL OF VIROLOGY, 2003, 77 (13) :7361-7366
[7]   Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors [J].
Ferrari, FK ;
Samulski, T ;
Shenk, T ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3227-3234
[8]   Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis [J].
Fisher, KJ ;
Gao, GP ;
Weitzman, MD ;
DeMatteo, R ;
Burda, JF ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1996, 70 (01) :520-532
[9]   Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy [J].
Gao, GP ;
Alvira, MR ;
Wang, LL ;
Calcedo, R ;
Johnston, J ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11854-11859
[10]   Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector [J].
Greelish, JP ;
Su, LT ;
Lankford, EB ;
Burkman, JM ;
Chen, HY ;
Konig, SK ;
Mercier, IM ;
Desjardins, PR ;
Mitchell, MA ;
Zheng, XG ;
Leferovich, J ;
Gao, GP ;
Balice-Gordon, RJ ;
Wilson, JM ;
Stedman, HH .
NATURE MEDICINE, 1999, 5 (04) :439-443